Hear from DEA, FDA, State Attorney Generals, U.S. Attorneys
More than a dozen manufacturers, distributors, top law firm leaders, and more at ACI's Inaugural Summit on Controlled Substances
Federal and state authorities continue to go after opioid manufacturers, distributors, pharmacies, pharmacists, physicians, nurses— anyone and everyone who has a hand in the chain of custody for these controlled substances. Nobody is immune.
In response to this most difficult and challenging landscape, this conference provides a forum for stakeholders to discuss current challenges, benchmark strategies, and join together to best prepare for the future of this critical and fast-paced industry. Highlights of this year's event include:
- Reassessing your Responsibilities in Light of the Changing Scope of Suspicious Order Monitoring Requirements
- Evolution of Abuse-Deterrent Opioid Drug Products
- Understanding and Comparing State Prescription Drug Monitoring Programs
- Diving into the State, County, and City Opioid-Related Investigations
Our stellar program faculty includes representatives from Center for Lawful Access and Abuse Deterrence, Daiichi Sankyo, Inc., Eisai, Inc., Independent Pharmacy Cooperative, Miami Luken, Purdue Pharma L.P., Stericycle Inc., Teva Pharmaceuticals, and more.
Full information on the forum can be found at
American Conference Institute